why choose us

First received: January 24, 2023

Clinical Trial: ALIVE-EA Clinical Study

Study Type: Expanded Access


Brief Summary: A prospective, multi-center, single-arm study. This study will enroll a maximum of 35 subjects treated with the Revivent TC System.

Read more